Get started
Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ALDX chart


Full chart

ALDX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪285.24 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.75 USD
Net income (FY)
‪−37.54 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪57.82 M‬
Beta (1Y)
0.85

Employees


Employees (FY)
10
Change (1Y)
−5 −33.33%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.75 M‬ USD

About Aldeyra Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Todd C. Brady
Website
aldeyra.com
Headquarters
Lexington
Founded
2004
FIGI
BBG0029H8ZF6
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALDX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALDX is 4.76 USD — it has decreased by −1.84% in the past 24 hours. Watch Aldeyra Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aldeyra Therapeutics, Inc. stocks are traded under the ticker ALDX.
ALDX stock has fallen by −2.44% compared to the previous week, the month change is a 0.21% rise, over the last year Aldeyra Therapeutics, Inc. has showed a 37.03% increase.
We've gathered analysts' opinions on Aldeyra Therapeutics, Inc. future price: according to them, ALDX price has a max estimate of 12.00 USD and a min estimate of 8.00 USD. Watch ALDX chart and read a more detailed Aldeyra Therapeutics, Inc. stock forecast: see what analysts think of Aldeyra Therapeutics, Inc. and suggest that you do with its stocks.
ALDX reached its all-time high on Sep 26, 2018 with the price of 16.70 USD, and its all-time low was 1.42 USD and was reached on Oct 16, 2023. View more price dynamics on ALDX chart.
See other stocks reaching their highest and lowest prices.
ALDX stock is 3.43% volatile and has beta coefficient of 0.85. Track Aldeyra Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Aldeyra Therapeutics, Inc. there?
Today Aldeyra Therapeutics, Inc. has the market capitalization of ‪285.24 M‬, it has decreased by −10.13% over the last week.
Yes, you can track Aldeyra Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Aldeyra Therapeutics, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ALDX earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.25 USD resulting in a −1.16% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about Aldeyra Therapeutics, Inc. earnings.
Aldeyra Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach ‪19.80 M‬ USD.
ALDX net income for the last quarter is ‪−15.11 M‬ USD, while the quarter before that showed ‪−16.85 M‬ USD of net income which accounts for 10.30% change. Track more Aldeyra Therapeutics, Inc. financial stats to get the full picture.
No, ALDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 10.00 employees. See our rating of the largest employees — is Aldeyra Therapeutics, Inc. on this list?
Like other stocks, ALDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aldeyra Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aldeyra Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aldeyra Therapeutics, Inc. stock shows the sell signal. See more of Aldeyra Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.